Vitamin D (vitD) deficiency may have importance in some diseases, but there is a lack of data in our country to clarify the current situation. Our aim was to examine the basic characteristics of patients' vitD status, and the ratio of vitD deficiency and its relation to certain diseases, assess seasonality and trends, and reveal the indirect impact of the COVID-19 pandemic on vitD supplementation at the patient population level. Anonymized data on 25(OH)D test results were obtained from the clinical data registry of a tertiary teaching hospital covering the period between 1 January 2015 and 30 June 2021. VitD consumption (pharmacy sale) data were retrieved from the database of the National Health Insurance Fund of Hungary in order to calculate the defined daily dose (DDD)/1,000 inhabitants/day. Descriptive statistics and odds ratios with their 95% confidence intervals were calculated. The two-sample -test and F-test were used to analyze our patients' data. Significant differences were considered if <0.05. Altogether, 45,567 samples were investigated; the mean age was 49 ± 19.1 years and 68.4% of them were female subjects. Overall, 20% of all patients had hypovitaminosis D, and just over 7% of patients had vitD deficiency. Male subjects had higher odds for hypovitaminosis or vitD deficiency (65.4 ± 28.2 nmol/L 68.4 ± 28.4 nmol/L; <0.0001). The mean 25(OH)D concentration has changed during the year, reaching a peak in September and a minimum in February. Patients with diseases of the circulatory system, genitourinary system, certain conditions originating in the perinatal period, and "sine morbo" (i.e., without a disease; such as those aged over 45 years and female teenagers) had statistically higher odds for lower 25(OH)D concentrations ( <0.00001). VitD consumption showed seasonality, being higher in autumn and winter. A slight increase started in the season of 2017/18, and two huge peaks were detected at the beginning of 2020 and 2021 in association with the COVID-19 waves. Our data are the first to describe data concerning vitD in our region. It reinforces the notion of vitD supplementation for some risk groups and also in healthy individuals. To prevent the winter decline, vitD supplementation should be started in September. This and the results during the COVID-19 pandemic highlight the importance of health education encouraging vitamin D supplementation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374949PMC
http://dx.doi.org/10.3389/fphar.2023.1232285DOI Listing

Publication Analysis

Top Keywords

vitd deficiency
8
vitd
5
data
5
years' experience
4
experience trends
4
trends serum
4
serum 25-hydroxy
4
25-hydroxy vitamin
4
vitamin concentration
4
concentration vitamin
4

Similar Publications

Severe vitamin D (vitD) deficiency is a very common condition in patients with pulmonary arterial hypertension (PAH) and it is predictor of poor prognosis. There is emerging evidence suggesting a connection between the insufficient response to phosphodiesterase-5 inhibitors (PDE5i) and vitD deficiency in patients with PAH. In the present translational study, vitD deficiency was induced in Wistar rats by exposure to vitD free diet for 5 weeks and followed by Su5416 administration and hypoxia (10%) for 3 weeks, a standard experimental model of PAH.

View Article and Find Full Text PDF

Interaction of Vitamin D-BODIPY With Fat Cells and the Link to Obesity-associated Vitamin D Deficiency.

Anticancer Res

January 2025

Section of Endocrinology, Diabetes, Nutrition and Weight Management, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, U.S.A.;

Background/aim: Obese individuals often exhibit vitamin D deficiency, potentially due to sequestration in fat cells. Little is known about how vitamin D enters adipocytes and associates with the intracellular lipid droplet.

Materials And Methods: Newly differentiated human and mouse (3T3-L1) adipocytes and primary mouse adipocytes were treated with vitamin D covalently linked to green fluorescent BODIPY (VitD-B) or Green BODIPY (GB) as control.

View Article and Find Full Text PDF
Article Synopsis
  • - China is facing a significant public health challenge with a high prevalence of Type 2 Diabetes Mellitus (T2DM), particularly due to lifestyle changes and vitamin D (VitD) deficiency, which affects 70-80% of these patients.
  • - The study utilized advanced techniques to compare protein expressions between T2DM patients with and without VitD deficiency, identifying 63 differentially expressed proteins, with four selected for further analysis.
  • - Findings suggest that proteins MMP9 and ICAM3 are more abundant in patients with sufficient VitD, indicating they may play crucial roles in understanding the mechanisms behind VitD deficiency in T2DM.
View Article and Find Full Text PDF
Article Synopsis
  • - Vitamin D insufficiency and deficiency are common in chronic kidney disease (CKD) patients, prompting a study to create a pharmacokinetic model for oral cholecalciferol (VitD) and its metabolites in this population.
  • - The study involved 29 CKD patients who were given a single dose of oral VitD, using nonlinear mixed effects modeling to analyze how the drug and its metabolites are processed in the body.
  • - The results indicate that personalized dosing strategies of 600 to 1000 I.U. of VitD per day may be ideal for reaching target 25-hydroxyvitamin D levels, potentially improving treatment for CKD patients.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to determine vitamin D levels in patients with renal cell carcinoma (RCC), bladder cancer (BC), and prostate cancer (PC) using advanced UPLC-MS/MS technology to establish a clear picture of their vitamin D status.
  • A total of 170 participants were analyzed for various vitamin D metabolites, revealing significantly lower levels of 25(OH)D, 25(OH)D3, and C3-epi in cancer patients compared to healthy controls.
  • The findings highlighted a positive correlation between 25(OH)D3 levels and free vitamin D levels, with most cancer patients showing vitamin D deficiency, emphasizing the potential diagnostic value of vitamin D measurements in differentiating healthy individuals from those with urinary system cancers
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!